Reduced cartilage proteoglycan loss during zymosan-induced gonarthritis in NOS2-deficient mice and in anti-interleukin-1-treated wild-type mice with unabated joint inflammation

Arthritis and Rheumatism

Volumn 41, Issue 4, 1998, Pages 634-646

  Van De Loo, Fons A J ^a   Arntz, Onno J ^a   Van Enckevort, Frank H J ^a   Van Lent, Peter L E M ^a   Van Den Berg, Wim B ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1 ANTIBODY; PROTEOGLYCAN; ZYMOSAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARTILAGE DEGENERATION; IMMUNOPATHOGENESIS; INFLAMMATION; KNEE ARTHRITIS; MOUSE; NONHUMAN; OXIDATION; PRIORITY JOURNAL; PROTEOGLYCAN SYNTHESIS;

ANIMALS; ANTIBODIES, MONOCLONAL; ARTHRITIS; CARTILAGE, ARTICULAR; CHONDROCYTES; DEPRESSION, CHEMICAL; HETEROZYGOTE; HYPERTROPHY; INFLAMMATION MEDIATORS; INSULIN-LIKE GROWTH FACTOR I; INTERLEUKIN-1; KNEE JOINT; MALE; MICE; MICE, INBRED C57BL; MICE, MUTANT STRAINS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; OSSIFICATION, HETEROTOPIC; PROTEOGLYCANS; SYNOVIAL MEMBRANE; ZYMOSAN;

EID: 0031926345     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/1529-0131(199804)41:4<634::AID-ART10>3.0.CO;2-1     Document Type: Article

References (53)

1. Moncada S, Palmer RMJ, Higgs EA. Nitric oxide: physiology, pathology and pharmacology. Pharmacol Rev 1991;43:109-41.
2. Koshland DE. The molecule of the year [editorial comment]. Science 1992;258:1861.
3. Moilanen E, Vapaatalo H. Nitric oxide in inflammation and immune response. Ann Med 1995;27:359-67.
4. Ahlqvist J, österlund K. Possible role of inducible nitric oxide synthase in articular chondrocytes in the pathogenesis of arthritic swelling [letter]. Arthritis Rheum 1995;38:1529-30.
5. Boughton-Smith NK, Ghelani A. Role of induced nitric oxide synthase and increased NO levels in zymosan peritonitis in the rat. Inflamm Res 1995;44:5149-50.
6. Ignarro LJ, Fukuto JM, Griscavage JM, Rogers NE, Byrns RE. Oxidation of nitric oxide in aqueous solutions to nitrite but not to nitrate: comparison with enzymatically formed nitric oxide from L-arginine. Proc Natl Acad Sci U S A 1993;90:8103-7.
7. Farrell AJ, Blake DR, Palmer RMJ, Moncada S. Increased concentrations of nitrite in synovial fluid and serum suggest increased nitric oxide synthesis in rheumatic diseases. Ann Rheum Dis 1992;51:1219-22.
8. g-monomethyl-L-arginine. J Exp Med 1994;179:651-60.
9. Van de Loo FAJ, Kuiper S, van Enckevort FHJ, Arntz OJ, van den Berg WB. Interleukin-6 ameliorates cartilage destruction during experimental arthritis: a study in interleukin-6-deficient mice. Am J Pathol 1997;151:177-91.
10. Cannon GW, Openshaw SJ, Hibbs JB Jr, Hoidal JR, Huecksteadt TP, Griffiths MM. Nitric oxide production during adjuvant-induced and collagen-induced arthritis. Arthritis Rheum 1996;39: 1677-84.
11. Stichtenoth DO, Fauler J, Zeidler H, Frölich JC. Urinary nitrate excretion is increased in patients with rheumatoid arthritis and reduced by prednisolone. Ann Rheum Dis 1995;54:820-4.
12. Grabowski PS, England AJ, Dykhuizen R, Copland M, Benjamin N, Reid DM, et al. Elevated nitric oxide production in rheumatoid arthritis: detection using the fasting urinary nitrate:creatinine ratio. Arthritis Rheum 1996;39:643-7.
13. Rediske JJ, Koehne CF, Zhang B, Lotz M. The inducible production of nitric oxide by articular cell types. Osteoarthritis Cartilage 1994;2:199-206.
14. Fukuda K, Kumano F, Takayama M, Saito M, Otani K, Tanaka S. Zonal differences in nitric oxide synthesis by bovine chondrocytes exposed to interleukin-1. Inflamm Res 1995;44:434-7.
15. Hayashi T, Abe E, Yamate T, Taguchi Y, Jasin HE. Nitric oxide production by superficial and deep articular chondrocytes. Arthritis Rheum 1997;40:261-9.
16. Palmer RMJ, Hichery MS, Charles IG, Moncada S, Bayliss MT. Induction of nitric oxide synthase in human chondrocytes. Biochem Biophys Res Commun 1993;193:398-405.
17. Sakurai H, Kohsaka H, Liu MF, Higashiyama H, Hirata Y, Kanno K, et al. Nitric oxide production and inducible nitric oxide synthase expression in inflammatory arthritides. J Clin Invest 1995;96:2357-63.
18. Grabowski PS, Macpherson H, Ralston SH. Nitric oxide production in cells derived from the human joint. Br J Rheumatol 1996;35:207-12.
19. McInnes IB, Leung BP, Field M, Wei XQ, Huang FP, Sturrock RD, et al. Production of nitric oxide in the synovial membrane of rheumatoid and osteoarthritis patients. J Exp Med 1996;184:1519-24.
20. Stefanovic-Racic M, Meyers K, Meschter C, Coffey JW, Hoffman RA, Evans CH. N-monomethyl arginine, an inhibitor of nitric oxide synthase, suppresses the development of adjuvant arthritis in rats. Arthritis Rheum 1994;37:1062-9.
21. McCartney-Francis N, Allen JB, Mizel DE, Albina JE, Xie Q-W, Mathan CF, et al. Suppression of arthritis by an inhibitor of nitric oxide synthase. J Exp Med 1993;178:749-54.
22. Verissimo de Mello SB, Novaes GS, Laurindo IMM, Muscara MN, de Barros Maciel FMD, Cossermelli W. Nitric oxide synthase inhibitor influences prostaglandin and interleukin 1 production in experimental arthritic joints. Inflamm Res 1997;46:72-7.
23. Giordano M, Vermeulen M, Trevani AS, Dran G, Andonegui G, Geffner JR. Nitric-oxide synthase inhibitors enhance plasma levels of corticosterone and ACTH. Acta Physiol Scand 1996;157:259-64.
24. Van de Loo FAJ, Joosten LAB, van Lent PLEM, Arntz OJ, van den Berg WB. Role of interleukin-1, tumor necrosis factor α, and interleukin-6 in cartilage proteoglycan metabolism and destruction: effect of in situ blocking in murine antigen- and zymosan-induced arthritis. Arthritis Rheum 1995;38:164-72.
25. Van de Loo FAJ, Arntz OJ, Otterness IG, van den Berg WB. Protection against cartilage proteoglycan synthesis inhibition by antiinterleukin 1 antibodies in experimental arthritis. J Rheumatol 1992;19:348-56.
26. Van den Berg WB, Joosten LAB, Helsen MMA, van de Loo AAJ. Amelioration of established murine collagen induced arthritis with anti-IL-1 treatment. Clin Exp Immunol 1994,95:237-43.
27. MacMicking JD, Nathan C, Hom G, Chartrain N, Fletcher DS, Trumbauer M, et al. Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase. Cell 1995;81:641-50.
28. De Waal RMW, Schrijver G, Bogman MJJR, Assmann KJM, Koene RAP. An improved sensitive and simple microassay of mouse complement. J Immunol Methods 1988;108:213-21.
29. Sweep CGJ, van der Meer MJM, Hermus ARMM, Smals AGH, van der Meer JWM, Pesman GJ, et al. Chronic Stimulation of the pituitary-adrenal axis in rats by interleukin-1β infusion: in vivo and in vitro studies. Endocrinology 1992;130:1153-64.
30. Keystone EC, Schorlemmer HU, Pope C, Allison AC. Zymosan-induced arthritis: a model of chronic proliferative arthritis following activation of the alternative pathway of complement. Arthritis Rheum 1977,20:1396-401.
31. Schalkwijk J, Joosten LAB, van den Berg WB, van Wyk JJ, van de Putte LBA. Insulin-like growth factor stimulation of chondrocyte proteoglycan synthesis by human synovial fluid. Arthritis Rheum 1989;32:66-71.
32. Verschure PJ, Joosten LAB, van de Loo FAJ, van den Berg WB. IL-1 has no direct role in the IGF-1 non-responsive state during experimentally induced arthritis in mouse knee joints. Ann Rheum Dis 1995;54:976-82.
33. Deakin AM, Payne AN, Whittle BJR, Moncada S. The modulation of IL-6 and TNF-α release by nitric oxide following stimulation of J774 cells with LPS and IFN-J. Cytokine 1995;7:408-16.
34. Eigler A, Moeller J, Endres S. Exogenous and endogenous nitric oxide attenuates tumor necrosis factor synthesis in murine macrophage cell line RAW 264.7. J Immunol 1995;154:4048-54.
35. Hill JR, Corbett JA, Kwon G, Marshall CA, McDaniel ML. Nitric oxide regulates interleukin 1 bioactivity released from murine macrophages. J Biol Chem 1996;271:22672-8.
36. Ianaro A, O'Donell CA, Di Rosa M, Liew FY. A nitric oxide synthase inhibitor reduces inflammation, down-regulates inflammatory cytokines and enhances interleukin-10 production in carageenin-induced oedema in mice. Immunology 1994;82:370-5.
37. Rivier C, Shen GH. In the rat, endogenous nitric oxide modulates the response of the hypothalamic-pituitary-adrenal axis to interleukin-1 beta, vasopressin, and oxytocin. J Neurosci 1994;14: 1985-93.
38. Turnbull AV, Rivier C. Corticotropin-releasing factor, vasopressin, and prostaglandins mediate, and nitric oxide restrains, the hypothalamic-pituitary-adrenal response to acute local inflammation in the rat. Endocrinology 1996;137:455-63.
39. Andersson SE, KÄllström L, Malm M, Miller-Larsson A, Axelsson B. Inhibition of nitric oxide synthase reduces Sephadex-induced oedema formation in the rat lung: dependence on intact adrenal function. Inflamm Res 1995;44:418-22.
40. Liew FY. Regulation of lymphocyte functions by nitric oxide. Curr Opin Immunol 1995;7:396-9.
41. Van de Loo FAJ, Arntz OJ, van den Berg WB. Effect of interleukin 1 and leukemia inhibitory factor on chondrocyte metabolism in articular cartilage from normal and interlcukin-6-deficient mice: role of nitric-oxide and IL-6 in the suppression of proteoglycan synthesis. Cytokine 1997;9:453-62.
42. Järvinen TAH, Moilanen T, Järvinen TLN, Moilanen E. Nitric oxide mediates interleukin-1 induced inhibition of glycosaminoglycan synthesis in rat articular cartilage. Med Inflamm 1995;4:107-11.
43. Taskiran D, Stefanovic-Racic M, Georgescu H, Evans C. Nitric oxide mediates suppression of cartilage proteoglycan synthesis by interleukin-1. Biochem Biophys Res Commun 1994;200:142-8.
44. Stefanovic-Racic M, Taskiran D, Evans CH. Modulation of chondrocyte proteolgycan synthesis by endogeneously produced nitric oxide. Inflamm Res 1995;44:5216-7.
45. Hauselmann HJ, Oppliger L, Michel BA, Stefanovic-Racic M, Evans CH. Nitric oxide and proteoglycan biosynthesis by human articular chondrocytes in alginate culture. FEBS Lett 1994;352: 361-4.
46. Murrell GAC, Jang D, Williams RJ. Nitric oxide activates metalloproteinase enzymes in articular cartilage. Biochem Biophys Res Commun 1995;206:15-21.
47. Stefanovic-Racic M, Morales TI, Taskiran D, McIntyre LA, Evans CH. The role of nitric oxide in proteoglycan turnover by bovine cartilage organ cultures. J Immunol 1996;156:1213-20.
48. Hanglow AC, Rowan K, Lusch L, Coffey JW. Degradation of bovine cartilage proteoglycan in vitro is enhanced by inhibition of nitric oxide synthase. Inflamm Res 1995;44:S151-2.
49. Tyler JA. Insulin-like growth factor 1 can decrease degradation and promote synthesis in cartilage exposed to cytokines. Biochem J 1989;260:543-8.
50. Gilkeson GS, Mudgett JS, Seldin ME, Ruiz P, Alexander AA, Misukonis MA, et al. Clinical and serologic manifestations of autoimmune diseases in MRL-lpr/lpr mice lacking nitric oxide synthase type 2. J Exp Med 1997;186:365-73.
51. Verschure PJ, van Marie J, Joosten LAB, van den Berg WB. Chondrocyte IGF-1 receptor expression and responsiveness to IGF-1 stimulation in mouse articular cartilage during various phases of experimentally-induced arthritis. Ann Rheum Dis 1995; 54:645-53.
52. Blanco FJ, Ochs RL, Schwarz H, Lotz M. Chondrocyte apoptosis induced by nitric-oxide. Am J Pathol 1995;146:75-85.
53. Arend WP, Dayer J-M. Inhibition of the production and effects of interleukin-1 and tumor necrosis factor α in rheumatoid arthritis. Arthritis Rheum 1995;38:151-60.